Text Size
5 studies found for:    14996676 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa-2a + ribavirin
2 Completed
Has Results 		Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients
Condition: Hepatitis C, Chronic
Intervention: Drug: Pegylated interferon alfa-2a plus ribavirin
3 Unknown † Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
4 Terminated EXtended Therapy in Hepatitis C Genotype 3 Infected Patients
Condition: Chronic Hepatitis C
Intervention: Drug: Peginterferon alfa-2b (Pegetron) plus ribavirin (Rebetol)
5 Completed A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients
Conditions: Chronic Hepatitis C;   Genotype
Interventions: Drug: pegylated interferon alpha 2a and ribavirin;   Drug: Pegylated interferon alfa-2a and ribavirin
To Top

† Indicates status has not been verified in more than two years